Home
Neurocrine Biosciences, Inc.

Neurocrine Biosciences, ... Market Share Analysis for November 2025

Neurocrine Biosciences, Inc. is an American biopharmaceutical company founded in 1992. The company is headquartered in San Diego, California, and led by CEO Kevin Gorman. Neurocrine develops treatments for neurological and endocrine-related diseases and disorders.

Health > Biotechnology and Pharmaceuticals

Domainneurocrine.com

Year Founded1992

Employees1001 - 5000

Annual Revenue> $1B

Neurocrine Biosciences, Inc.

Neurocrine Biosciences, Inc. (including company regionals)

neurocrine.com

See more website traffic and engagement information

Neurocrine Biosciences, Inc. Revenue up to November 2025 is > 1B

revenue generated by Neurocrine Biosciences, Inc. top domains

Neurocrine Biosciences, Inc. top domains revenue over 3 years

Revenue for Neurocrine Biosciences, Inc. top domains

neurocrine.com> 1B

See more with Sales Intelligence

Total visits to Neurocrine Biosciences, Inc.'s top domains

Understand Neurocrine Biosciences, Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

neurocrine.com27.8K

See more with Sales Intelligence

Avg. visit duration in Neurocrine Biosciences, Inc.'s top domains

Analyze Neurocrine Biosciences, Inc. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

neurocrine.com00:00:51

See more with Sales Intelligence

Avg. pageviews on Neurocrine Biosciences, Inc.'s top domains

See how Neurocrine Biosciences, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

neurocrine.com1.61

See more with Sales Intelligence

Neurocrine Biosciences, Inc. top competitors by domain

Top similar sites in November 2025, ranked by their affinity

bio-quant.comCompany NameBio-QuantEmployees51 - 200HQUnited States, California, San DiegoAnnual revenue--Total visits--Health > Biotechnology and Pharmaceuticals

Top technologies used by Neurocrine Biosciences, Inc.

These are the website technologies, by industry, used by Neurocrine Biosciences, Inc. top domains

Email Services (4)

Sendgrid

Content Management System (3)

WordPress

Widget (3)

Twemoji

Advertising (2)

DoubleClick

More Technologies

11

See all

News & Signals from Neurocrine Biosciences, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsNeurocrine Biosciences, Inc. is developing NLRP3 inhibitors for multiple diseases.Under the terms of the deal, Neurocrine and TransThera will develop NLRP3 inhibitors for "multiple diseases."

NewsNeurocrine Biosciences, Inc. hired Mike Sibley as Senior Vice President and General Manager of the company's Neuropsychiatry franchise on Oct 6th '25.SAN DIEGO, Oct. 6, 2025 /PRNewswire/ - Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the appointment of Mike Sibley as Senior Vice President and General Manager of the company's Neuropsychiatry franchise.

NewsNeurocrine Biosciences, Inc. attends event 38th annual Psych Congress 2025.Neurocrine Biosciences to present new Data from Phase 2 Study of osavampator in Adults with Major Depressive Disorder at 38th annual Psych Congress 2025.